Certain discarded drugs will soon cost pharma companies
Millions of dollars worth of injectable and infusible drugs go to waste each year, as they typically come in single-dose vials and dosing varies depending on the patient. Starting next year, though, those unused doses will cost pharma companies.
According to an infrastructure bill passed last year, drug manufacturers must refund Medicare for unused drugs in single-dose vials beginning in 2023. Medicare also included the update in its latest proposed rule, according to STAT, which first reported the news.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
